Dec. 27, 2018 Price forecast | 2 weeks: -0.10% | 1 month: -0.43% | 3 months: 5.53%

APEN stock forecast

Our latest prediction for Apollo Endosurgery, Inc.'s stock price was made on the Dec. 27, 2018 when the stock price was at 3.24$.

In the short term (2weeks), APEN's stock price should underperform the market by -0.10%. During that period the price should oscillate between -11.46% and +18.53%.

In the medium term (3months), APEN's stock price should outperform the market by 5.53%. During that period the price should oscillate between -21.50% and +45.88%.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company, which engages in the design, development, and commercialization of medical devices. It offers medical devices for bariatric and gastrointestinal procedures under the ORBERA and OverStitch brands. The company was founded by Christopher J. Gostout in 2006 and is headquartered in Austin, TX.

At the moment the company generates 57M USD in revenues.

On its last earning announcement, the company reported a loss of -1.84$ per share.

The book value per share is 2.52$

Apollo Endosurgery, Inc. website

Three months stock forecastDec. 27, 2018


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
57M 51.50% -33M -57.30% -40M -1.84 - - 22M 2.52 -20M -1M -21M